desmoid tumors: phase 3 clinical trial data with nirogacestat shows promise
Published 1 year ago • 415 plays • Length 3:01Download video MP4
Download video MP3
Similar videos
-
2:02
nirogacestat being evaluated for desmoid tumors in adults and children
-
1:16
nirogacestat’s mechanism of action to treat desmoid tumors
-
1:52
defi trial: nirogacestat vs placebo for patients with progressing desmoid tumors
-
2:22
treatment options for desmoid tumors, including nirogacestat in children
-
2:56
#esmo22 highlights on nirogacestat in patients with progressing desmoid tumours: the defi study
-
4:40
nirogacestat success for desmoid tumours
-
6:07
desmoid tumors and the approval of ogsiveo
-
1:36
defi: nirogacestat demonstrates improved pfs and orr in progressing desmoid tumors
-
3:36
past, present, and future treatment options for desmoid tumors
-
1:45
what are desmoid tumors
-
1:24
what are desmoid tumors?
-
59:05
addressing key questions about the latest diagnostic and therapeutic advances in desmoid tumors
-
0:45
nirogacestat emerges as a treatment for desmoid tumor: 2022 esmo florida
-
1:21
desmoid tumors in children vs adults
-
4:14
what are desmoid tumors
-
5:25
desmoid tumor (nord)
-
2:38
imetelstat on-target activity correlates with clinical benefits in mds: imerge findings
-
2:50
desmoid tumor overview
-
3:58
prognosis & advances in treatment strategies for sf3b1-mutant mds